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Abstract A putative guanine nucleotide exchange factor (GEF),
termed leukemia-associated RhoGEF (LARG), was recently
identified upon fusion to the coding sequence of the MLL gene in
acute myeloid leukemia. Although the function of LARG is still
unknown, it exhibits a number of structural domains suggestive
of a role in signal transduction, including a PDZ domain, a LH/
RGS domain, and a Dbl homology/pleckstrin homology domain.
Here, we show that LARG can activate Rho in vivo.
Furthermore, we present evidence that LARG is an integral
component of a novel biochemical route whereby G protein-
coupled receptors (GPCRs) and heterotrimeric G proteins of
the GK12 family stimulate Rho-dependent signaling path-
ways. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The Rho family of GTP-binding proteins plays an impor-
tant role in the regulation of cell morphology, cell aggrega-
tion, tissue polarity, cytokinesis, cell motility and also in
smooth muscle contraction [1^3]. Recent evidence suggests
that Rho proteins are also integral components of signaling
pathways regulating gene expression. For example, activated
alleles of Rho induce expression from the serum responsive
element (SRE) through the activation of the serum response
factor [4], and two members of the Rho family of GTPases,
Rac and Cdc42, regulate the activity of the c-Jun amino-ter-
minal kinase (JNK) [5], which, in turn, phosphorylates tran-
scription factors such as c-Jun and ATF2 thereby stimulating
their transcriptional activity [6].
Rho proteins are members of the Ras superfamily of
GTPases, which cycle between an inactive GDP-bound and
an active GTP-bound form under the tight regulation of gua-
nine nucleotide exchange factors (GEFs) and GTPase-activat-
ing proteins (GAPs). Whereas GEFs promote the exchange of
GDP for GTP thus activating Ras-like proteins [7], GAPs
enhance the low intrinsic rate of GTP hydrolysis of small
GTPases and are negative modulators [8]. Many GEFs for
GTP-binding proteins of the Rho family, including dbl, ost,
lfc, lbc, vav, ect2, tim, and net were discovered by virtue of
their ability to transform murine ¢broblasts upon overexpres-
sion or when activated by truncations [9]. These proteins share
a highly related structural domain of about 250 amino acids,
termed Dbl homology (DH) domain, adjacent to a pleckstrin
homology (PH) domain [9]. The DH domain is responsible for
the nucleotide exchange activity towards GTPases of the Rho
family [10,11], and often the overexpression of the DH/PH
domain alone is su⁄cient to stimulate guanine nucleotide ex-
change on Rho proteins in vivo [10]. However, how cell sur-
face receptors regulate the activity of these GEFs thereby
stimulating Rho proteins is still largely unknown.
Of interest, in a recent study Kourlas et al. have identi¢ed a
novel putative RhoGEF, termed leukemia-associated Rho-
GEF (LARG), whose coding sequence was fused to that of
the MLL gene upon chromosomal rearrangement in a patient
with acute myeloid leukemia [12]. The predicted protein prod-
uct of the LARG gene includes a number of structural do-
mains suggestive of a function in signal transduction, includ-
ing a PDZ domain, a LH/RGS domain, and a tandem DH/
PH domain highly related to those of RhoGEFs [12]. How-
ever, the biological and/or biochemical activities of LARG are
still unknown. In this study, we present evidence that LARG
links G protein-coupled receptors (GPCRs) and heterotrimer-
ic G proteins of the GK12 family to Rho, thus providing a
mechanism by which this large family of cell surface receptors
activates Rho-dependent signaling pathways.
2. Materials and methods
2.1. Cloning of full length LARG cDNA and expression plasmids
A partial LARG cDNA (KIAA0382) encoding amino acids 795^
1544 was kindly provided by Dr. T. Nagase, Kazusa DNA Research
Institute, Japan. The upstream sequence of LARG was ampli¢ed by
the reverse transcription (RT)-PCR technique using human brain total
RNA, and was con¢rmed by sequencing. Sequence of the oligonucleo-
tides used for RT-PCR will be made available upon request. The full
coding sequence of LARG was subcloned in frame with that of an
AU1-tag in the pCEFL vector (pCEFL AU1 LARG) [13]. cDNAs
encoding LARG mutants were generated by restriction enzyme diges-
tion and polymerase chain reaction ampli¢cation using pCEFL AU1
LARG as a template.
Plasmids expressing AU1-tagged PDZ-RhoGEF, an AU5-tagged
form of Rho, activated forms of GK12, GK13 and GKq, and L-galac-
tosidase as well as m1 and PAR1 GPCRs were described previously
[13,14]. Reporter plasmid encoding the chloramphenicol acetyltrans-
ferase (CAT) gene under the control of mutant serum response ele-
ment from the c-fos promoter, which lacks the ternary complex factor
(TCF)-binding site (SREmutL), was kindly provided by Dr. R. Treis-
man [4].
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2.2. Cell lines and transfection
Human kidney 293T and murine NIH 3T3 cells were maintained in
Dulbecco’s modi¢ed Eagles’s medium (DMEM) (Life Technologies,
Inc.) supplemented with 10% fetal bovine serum and calf serum, re-
spectively. Transfection of DNA plasmids into these cells was carried
out using LipofectAMINE Plus, according to manufacturer’s proto-
col. For the transfection into 293T cells, tissue culture plates were
coated with poly-D-lysine to prevent cell detachment from the plates,
as described before [13].
2.3. In vivo Rho activation assay
In vivo Rho activity was assessed by a modi¢ed method described
elsewhere [15]. Brie£y, 293T cells were transfected with the DNA
encoding AU5-tagged wild type of Rho together with the indicated
plasmids. After serum starvation for 1 day, cells were lysed at 4‡C in a
bu¡er containing 20 mM HEPES, pH 7.4, 0.1 M NaCl, 1% Triton
X-100, 10 mM EGTA, 40 mM L-glycerophosphate, 20 mM MgCl2,
1 mM Na3VO4, 1 mM dithiothreitol, 10 Wg/ml aprotinin, 10 Wg/ml
leupeptin, and 1 mM phenylmethylsulfonyl £uoride. Lysates were in-
cubated with a GST fusion protein including the Rho-binding domain
(RBD) of rhotekin previously bound to glutathione-Sepharose beads,
followed by four washes with lysis bu¡er. GTP-bound forms of Rho
associated with GST-rhotekin-RBD were released from beads by an
addition of protein loading bu¡er, and quanti¢ed by Western blot
analysis using AU5 antibodies.
2.4. Co-immunoprecipitation and Western blot analysis
293T cells were transfected with vectors expressing AU1-tagged
wild type and mutant forms of LARG together with plasmids for
the activated forms of GK12, GK13 and GKq or for green £uorescent
protein (GFP) as a control. After culture for 48 h, cells were washed
twice with phosphate-bu¡ered saline and lysed at 4‡C in the lysis
bu¡er used for Rho activation assays. AU1-tagged wild type and
mutant forms of LARG were immunoprecipitated from the cleared
lysate with the speci¢c antibodies against AU1 (BABCO), and immu-
nocomplexes were recovered with the aid of Gamma-bind Sepharose
beads (Pharmacia). Lysates and anti-AU1 immunoprecipitates were
analyzed by Western blotting after sodium dodecyl sulfate^polyacryl-
amide gel electrophoresis, transferred to Immobilon-P Transfer Mem-
branes (Amersham Life Science) and immunoblotted with rabbit poly-
clonal anti-GKq (Santa Cruz Laboratories) or anti-GK12=13 and mouse
monoclonal AU1 antibody as indicated in the corresponding ¢gure.
Immunocomplexes were visualized by enhanced chemiluminescence
detection (Amersham Life Science) using goat anti-rabbit or goat
anti-mouse IgGs coupled to horseradish peroxidase as a secondary
antibody (Cappel).
2.5. Reporter gene assay
The SRE activity was determined as described previously [13].
Brie£y, NIH 3T3 cells were transfected with the indicated plasmids
together with pSREmutL, the reporter plasmid expressing a CAT
gene under the control of the mutant SRE lacking a TCF-binding
site, together with pcDNA3-L-galactosidase, a plasmid encoding the
enzyme L-galactosidase. After transfection, cells were cultured for
V24 h in serum free DMEM, stimulated with the indicated agonists
for an additional 6 h, when required, then lysed using reporter lysis
bu¡er (Promega). CAT and L-galactosidase activities were measured
as described previously [13].
3. Results and discussion
3.1. LARG induces the accumulation of Rho-GTP in vivo
The structure of the predicted LARG protein is highly re-
lated to that of PDZ-RhoGEF and a Drosophila RhoGEF,
DRhoGEF2 [12]. Indeed, these molecules share the presence
of a PDZ and a LH/RGS domain in addition to a tandem
DH/PH domain (Fig. 1). The PDZ domain is a protein^pro-
tein interacting domain, which is thought to participate in the
formation of macromolecular complexes [16]. The LH/RGS
domain exhibits sequence similarity to GAPs for heterotrimer-
ic G proteins [13,17]. LARG is also related to p115-RhoGEF,
which exhibits a LH/RGS domain but not a PDZ domain
[18].
We ¢rst con¢rmed that the open reading frame of the
LARG gene expresses a protein of the predicted molecular
weight, 173 kDa. As shown in Fig. 2, the epitope-tagged
form of LARG was detectably expressed in transiently trans-
fected 293T cells, albeit to a much lower level than that of
PDZ-RhoGEF that exhibits a similar molecular weight and
was used as a control. Next, we investigated whether LARG
can act as a Rho exchange factor by examining its ability to
stimulate the exchange of GDP for GTP on Rho using a
recently developed in vivo Rho guanine nucleotide exchange
assay [15]. For these experiments, 293T cells were transfected
with a plasmid encoding AU5-tagged Rho together with ex-
pression vectors for the AU1-tagged LARG and AU1-tagged
PDZ-RhoGEF or for GFP as a control. Lysates from trans-
fected cells were incubated with a GST fusion protein includ-
ing the RBD of rhotekin, previously bound to glutathione-
Sepharose beads. The levels of GTP-bound form of Rho as-
sociated with GST-rhotekin-RBD were quanti¢ed by Western
blot analysis using anti-AU5 antibodies. As shown in Fig. 2,
overexpression of LARG as well as PDZ-RhoGEF e¡ectively
increased the amount of GTP-bound form of Rho without
causing any changes in the expression levels of AU5-tagged
Fig. 1. Structures of RGS domain-containing RhoGEFs. Accession
numbers: LARG (KIAA0382), AF180681; PDZ-RhoGEF
(KIAA0380), AB002378; p115-RhoGEF, U64105; DRhoGEF2,
AF032870.
Fig. 2. In vivo activation of Rho by LARG and PDZ-RhoGEF.
293T cells were transfected with a DNA encoding AU5-tagged
RhoA together with plasmids for AU1-tagged LARG and PDZ-
RhoGEF or for GFP as a control. The level of GTP-bound form
of Rho in vivo was determined as described under Section 2.
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Rho, thus indicating that LARG and PDZ-RhoGEF are able
to act as RhoGEFs in vivo.
3.2. LARG associates with GK12 and GK13 heterotrimeric
G protein K subunits
GPCRs are key upstream regulators of Rho GTPases [19].
Furthermore, work from several laboratories indicates that
heterotrimeric G proteins of the G12 family, G12 and G13,
utilize Rho to induce the formation of actin-based stress ¢bers
[20], gene expression driven by serum response element
[21,22], and cellular transformation [21]. However, there is
still limited information on how G proteins and their coupled
receptors stimulate Rho. In this regard, it has recently been
shown that PDZ-RhoGEF and p115-RhoGEF can provide a
direct link between the GK12 family of heterotrimeric G pro-
tein K subunits and Rho. In addition, the GKq family of G
proteins has also been reported to activate Rho-dependent
signaling pathways [21,22]. However, how GKq communicates
to Rho is still completely unknown. Thus, the observation
that LARG exhibits a LH/RGS domain raised the possibility
that this RhoGEF may link these heterotrimeric G proteins to
Rho. To address this possibility, we investigated the ability of
LARG to associate with GK12, GK13 and GKq upon trans-
fection of 293T cells with a DNA vector encoding AU1-
tagged wild type LARG together with plasmids for GFP (as
a control) and activated forms of GK12 (GK12QL), GK13
Fig. 3. Interaction of LARG through its LH/RGS domain with heterotrimeric G protein K subunit of the G12 family. 293T cells were trans-
fected with expression vector for AU1-tagged wild type and mutant forms of LARG, whose structures are depicted in the upper panel, together
with plasmids carrying cDNAs for the constitutively activated mutants of (A) GK12, GK13 and (B) GKq as indicated. Lysates, prepared as de-
scribed under Section 2, were immunoprecipitated (IP) with anti-AU1 antibody and subjected to Western blot (WB) analysis using rabbit poly-
clonal antibodies against GK12=13 or GKq (A and B, respectively). In addition, total cellular lysate (TCL) was subjected to Western blot (WB)
analysis with G protein-speci¢c antisera and anti-AU1 antibodies as indicated.
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(GK13QL) and GKq (GKqQL). As shown in Fig. 3A,B, LARG
co-immunoprecipitated with GK12QL and GK13QL, but not
GKqQL. Similarly, we did not detect any speci¢c association
of LARG to GKs, GKi, or LQ subunits (not shown). Further-
more, as depicted in Fig. 3A (upper panel), we prepared DNA
constructs encoding an N-terminal deletion mutant of LARG,
lacking its RGS domain, and an epitope-tagged RGS domain
alone. Each protein was detectably expressed, as judged by
Western blot analysis using anti-epitope antibodies (Fig. 3A,
lower panel). As shown in Fig. 3A, the protein encoding the
RGS domain alone associated with GK12QL and GK13QL
e⁄ciently, whereas the LARG N-terminal deletion mutant,
lacking its LH/RGS domain, could not. These results indicate
that LARG associates physically with GK12 and GK13, and
that the LH/RGS domain is the molecular determinant of its
ability to form stable complexes with these G protein K sub-
units.
3.3. The RGS/LH domain of LARG diminishes the SRE
response elicited by GK12 and GK13 but not GKq
These results and recent published reports suggest that
GK12 proteins may signal to Rho through LH/RGS domain-
containing RhoGEFs [13,23]. To explore this possibility, we
examined the e¡ect of expression of LH/RGS domains de-
rived from LARG and PDZ-RhoGEF on SRE activation in-
duced by the constitutively active mutants of GK12, GK13 and
GKq, as these RGS domains might act as a dominant negative
molecules. As shown in Fig. 4, the induction of SRE by
GKqQL was una¡ected by the expression of the LH/RGS
domains of PDZ-RhoGEF and LARG. In contrast, these
RGS domains signi¢cantly inhibited the SRE activation in-
duced by the expression of GK12QL and GK13QL.
3.4. Evidence for a role of LARG downstream from LPA and
thrombin receptors
Next, we asked whether LARG might play a role in signal-
ing from GPCRs to Rho. In this regard, thrombin and LPA
receptors are able to couple to the GK12 family of heterotri-
meric G proteins [19], whereas m1 muscarinic acetylcholine
receptors represent typical GKq-coupled receptors. Stimula-
tion of both classes of GPCRs is known to induce Rho-de-
pendent signaling pathways [21,22]. Thus, we investigated the
ability of the RGS domains of LARG and PDZ-RhoGEF to
interfere with the activation of the SRE when induced by
these GPCRs. As shown in Fig. 5, the expression of the
RGS domains of LARG and PDZ-RhoGEF inhibited the
activation of SRE induced by thrombin and LPA receptors.
In contrast, the transcriptional response elicited by m1 recep-
tors was una¡ected. Taken together, these results suggest that
LARG and PDZ-RhoGEF can mediate in signaling from
G12- and G13-coupled receptors to Rho, whereas additional
molecular mechanisms may link Gq-coupled receptors to Rho
GTPases (Fig. 6).
Whether the MLL^LARG fusion protein exhibits also
RhoGEF activity is at present unknown. However, this fusion
protein includes the majority of the LARG coding sequence
but its PDZ domain [12]. Thus, it would be expected to retain
its ability to stimulate Rho proteins. In this regard, LARG is
likely to function as a Rho-speci¢c GEF, as it failed to induce
MAPK and JNK, typical responses elicited by Ras and Rac/
Cdc42, respectively, when overexpressed in a number of cel-
Fig. 4. Inhibition of GK12- and GK13-mediated SRE activation by
the RGS domain of LARG and PDZ-RhoGEF. NIH 3T3 cells
were co-transfected with pSREmutL and pCDNA3-L-gal together
with the indicated expression vectors. Cells were processed as de-
scribed under Section 2. The data represent CAT activity normal-
ized by the L-galactosidase activity present in each cellular lysate,
expressed as a percentage relative to that observed in control, and
are the mean þ S.E.M. of triplicate samples from a typical experi-
ment. Similar results were obtained in three independent experi-
ments.
Fig. 5. Inhibition of GPCR-mediated SRE activation by the RGS
domain of LARG and PDZ-RhoGEF. NIH 3T3 cells were co-trans-
fected with pSREmutL and pCDNA3-L-gal together with the ex-
pression vectors for m1 and PAR1 receptors or GFP (for LPA
stimulation) as well as plasmids expressing RGS domains of LARG
and PDZ-RhoGEF. Cells were stimulated with 100 WM carbachol
(Cch) for m1-transfected cells, 10 U/ml thrombin (Thr) for PAR1-
transfected cells, and 5 WM LPA for GFP-transfected cells for 6 h,
and were processed as described under Section 2. The data represent
CAT activity normalized by the L-galactosidase activity present in
each cellular lysate, expressed as a percentage relative to that ob-
served in control, and are the mean þ S.E.M. of triplicate samples
from a typical experiment. Similar results were obtained in three in-
dependent experiments.
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lular systems (data not shown). Furthermore, Rho and mole-
cules acting upstream from Rho, such as GK12/GK13 and cer-
tain GPCRs, can harbor transforming potential [24,25]. Thus,
these observations raise the possibility that aberrant expres-
sion of the MLL^LARG protein or signaling molecules acting
on Rho pathways may contribute to the development of acute
myelogenous leukemia, a possibility that warrants further in-
vestigation.
The striking structural similarity to PDZ-RhoGEF and to
the Drosophila DRhoGEF2 suggests that LARG and PDZ-
RhoGEF represent the mammalian homologs of DRhoGEF2.
Of interest, genetic analysis suggests that DRhoGEF2 acts
downstream of the concertina gene, a Drosophila GK12=13 ho-
molog involved in gastrulation during early embryogenesis
[26,27]. Thus, the GPCR-GK12=13-LARG/PDZ-RhoGEF-
Rho pathway may represent a signaling route highly con-
served throughout evolution. On the other hand, whether
LARG and PDZ-RhoGEF perform similar or distinct func-
tions is at the present unclear. Both RhoGEFs are ubiqui-
tously expressed and exhibit similar structural features. How-
ever, their C-terminal domain is highly divergent [12], which
may result in distinct biological activities. We expect that on-
going e¡orts aimed to disrupt the PDZ-RhOGEF and LARG
genes will soon provide a wealth of information on their
unique or mutually redundant functions.
Taken together, we can conclude that LARG represents a
novel RhoGEF whose aberrant expression as a fusion protein
to MLL may play a role in human acute myeloid leukemia. At
the molecular level, LARG can associate physically with GK12
and GK13 through its LH/RGS domain and stimulate the
accumulation of GTP-bound Rho, likely through its DH/PH
domain. Furthermore, available evidence suggests that LARG
is an integral component of a novel signaling route by which
the large family of G protein-linked receptors coupled to G12/
G13 can activate Rho, thereby initiating the activity of multi-
ple intracellular signaling pathways dependent on Rho
GTPases.
Acknowledgements: We thank Drs. T. Nagase and R. Treisman for
generously providing us with KIAA0382 and KIAA0380 DNA plas-
mids and pSREmutL vector, respectively.
References
[1] Hotchin, N.A. and Hall, A. (1996) Cancer Surv. 27, 311^322.
[2] Narumiya, S. (1996) J. Biochem. (Tokyo) 120, 215^228.
[3] Narumiya, S., Ishizaki, T. and Watanabe, N. (1997) FEBS Lett.
410, 68^72.
[4] Hill, C.S., Wynne, J. and Treisman, R. (1995) Cell 81, 1159^1170.
[5] Coso, O.A., Chiariello, M., Yu, J.C., Teramoto, H., Crespo, P.,
Xu, N., Miki, T. and Gutkind, J.S. (1995) Cell 81, 1137^1146.
[6] Ip, Y.T. and Davis, R.J. (1998) Curr. Opin. Cell. Biol. 10, 205^
219.
[7] Boguski, M.S. and McCormick, F. (1993) Nature 366, 643^654.
[8] Lamarche, N. and Hall, A. (1994) Trends Genet. 10, 436^440.
[9] Whitehead, I.P., Campbell, S., Rossman, K.L. and Der, C.J.
(1997) Biochim. Biophys. Acta 1332, F1^F23.
[10] Hart, M.J., Eva, A., Zangrilli, D., Aaronson, S.A., Evans, T.,
Cerione, R.A. and Zheng, Y. (1994) J. Biol. Chem. 269, 62^65.
[11] Hart, M.J., Eva, A., Evans, T., Aaronson, S.A. and Cerione,
R.A. (1991) Nature 354, 311^314.
[12] Kourlas, P.J. et al. (2000) Proc. Natl. Acad. Sci. USA 97, 2145^
2150.
[13] Fukuhara, S., Murga, C., Zohar, M., Igishi, T. and Gutkind, J.S.
(1999) J. Biol. Chem. 274, 5868^5879.
[14] Fukuhara, S., Marinissen, M.J., Chiariello, M. and Gutkind, J.S.
(2000) J. Biol. Chem. 275, 21730^21736.
[15] Ren, X.D., Kiosses, W.B. and Schwartz, M.A. (1999) EMBO J.
18, 578^585.
[16] Fanning, A.S. and Anderson, J.M. (1996) Curr. Biol. 6, 1385^
1388.
Fig. 6. Proposed mechanism whereby GPCRs stimulate Rho-dependent signaling pathways. The stimulation of certain GPCRs results in the ac-
tivation of GK12 and GK13 which, in turn, interact with LH/RGS domain-containing RhoGEFs such as LARG, PDZ-RhoGEF and p115-Rho-
GEF through their LH/RGS domains, thereby causing their activation. Subsequently, the activated RGS domain-containing RhoGEFs catalyze
the exchange of GDP for GTP on Rho through their DH/PH domain, which leads to the activation of Rho-dependent signaling pathways. Gq-
coupled receptors also stimulate Rho-mediated signaling pathways, albeit by a still poorly understood mechanism.
FEBS 24326 17-11-00
S. Fukuhara et al./FEBS Letters 485 (2000) 183^188 187
[17] Berman, D.M. and Gilman, A.G. (1998) J. Biol. Chem. 273,
1269^1272.
[18] Kozasa, T., Jiang, X., Hart, M.J., Sternweis, P.M., Singer, W.D.,
Gilman, A.G., Bollag, G. and Sternweis, P.C. (1998) Science 280,
2109^2111.
[19] Sah, V.P., Seasholtz, T.M., Sagi, S.A. and Brown, J.H. (2000)
Annu. Rev. Pharmacol. Toxicol. 40, 459^489.
[20] Buhl, A.M., Johnson, N.L., Dhanasekaran, N. and Johnson,
G.L. (1995) J. Biol. Chem. 270, 24631^24634.
[21] Fromm, C., Coso, O.A., Montaner, S., Xu, N. and Gutkind, J.S.
(1997) Proc. Natl. Acad. Sci. USA 94, 10098^10103.
[22] Mao, J., Yuan, H., Xie, W., Simon, M.I. and Wu, D. (1998)
J. Biol. Chem. 273, 27118^27123.
[23] Hart, M.J., Jiang, X., Kozasa, T., Roscoe, W., Singer, W.D.,
Gilman, A.G., Sternweis, P.C. and Bollag, G. (1998) Science
280, 2112^2114.
[24] Xu, N., Bradley, L., Ambdukar, I. and Gutkind, J.S. (1993) Proc.
Natl. Acad. Sci. USA 90, 6741^6745.
[25] Xu, N., Voyno-Yasenetskaya, T. and Gutkind, J.S. (1994) Bio-
chem. Biophys. Res. Commun. 201, 603^609.
[26] Hacker, U. and Perrimon, N. (1998) Genes Dev. 12, 274^284.
[27] Parks, S. and Wieschaus, E. (1991) Cell 64, 447^458.
FEBS 24326 17-11-00
S. Fukuhara et al./FEBS Letters 485 (2000) 183^188188
